#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B with anti factor IX Sexually transmitted disease Dupuytren's contracture Macular telangiectasia Peripheral primitive neuroectodermal tumour of soft tissue Anti-HLA antibody test positive Langerhans cell sarcoma Follicular lymphoma stage III Tuberous sclerosis complex Neurodermatitis Brain injury Osteomyelitis Bladder cancer Encephalopathy neonatal Infantile spasms More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Basic Information Ewing’s sarcoma recurrent – Life with Disease Paroxysmal nocturnal haemoglobinuria – Basic Information Glycogen storage disease type II – Treatment Netherton’s syndrome Primary immunodeficiency syndrome – Diagnostics Pleural mesothelioma malignant – Treatment Primary biliary cholangitis – Treatment Anaplastic thyroid cancer – Diagnostics Anaplastic thyroid cancer – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Diclofenac Epolamine Hdp-101 Sodium Ascorbate Belatacept POLYSORBATE 80 Mk-6194 GSKVX000000030810 Axitinib Cefiderocol Inclisiran Sodium Quercetin Zofenopril Calcium MZE829 Cft1946 His203-Crm197 Tucatinib Hydrocortisone Acetate Atrasentan Hydrochloride Alternaria Alternata (402) Keto-Isoleucine Calcium More therapies…

    Learn about Your Condition

    Non-obstructive cardiomyopathy Procedural hypotension Psoriasis Abortion threatened Marfan's syndrome Pain in extremity Anorexia nervosa Pancreatic carcinoma stage IV High-grade B-cell lymphoma Adenovirus infection Pancoast's tumour Ewing's sarcoma Graft infection Barrett's oesophagus Immune-mediated myositis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on the Safety of Intradermal mRNA COVID-19 Vaccine Bretovameran for Patients with Fibrodysplasia Ossificans Progressiva

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fibrodysplasia ossificans progressiva
    The Netherlands

  • Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    • Risankizumab
    Bulgaria Czechia France Germany Hungary Poland +1

  • Study on Zoledronic Acid and Placebo Before Parathyroid Surgery in Patients with Primary Hyperparathyroidism

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hyperparathyroidism primary
    Investigated Drugs:
    • Zoledronic Acid
    • Sodium Chloride
    Denmark

  • Study on Sodium Fluoride (18F) PET-CT Scans for Detecting Bone Changes in Psoriasis Patients at Risk of Psoriatic Arthritis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Sodium Fluoride (18F)
    The Netherlands

  • Study on Mesotherapy with Piroxicam and Lidocaine for Treating Tennis Elbow in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Epicondylitis
    Investigated Drugs:
    • PIROXICAM
    • Lidocaine Hydrochloride
    Portugal

  • Study on Ketoanalogue Supplementation for Muscle Protection in Patients with Stage 4 and 5 Chronic Kidney Disease on a Low Protein Diet

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Alpha-Ketophenylalanine Calcium
    • Hydroxi-Methionine Calcium
    • Keto-Isoleucine Calcium
    France
Previous Page
1 … 8 9 10 11 12 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!